Barely Significant
← all excerpts

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.

Cardiovasc Diabetol · 2024 · PMC10771642 · PMID 38184612

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

borderline significantp = 0.05actually significant
These differences in treatment effects were borderline significant (p = 0.05) (Fig. 3 E, F).

also in 3,467 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.